Investigational New Drugs

Edit Your Profile

Investigational New Drugs Journal

publication venue for

A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors: a North American brain tumor consortium report. 21:429-433. 2003
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy. 17:121-135. 1999
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor 2012

International Standard Serial Number (ISSN)

0167-6997

Electronic International Standard Serial Number (EISSN)

1573-0646